FIBROGEN Forum: Community User: NOK

Kommentare 212
Summer.76
Summer.76, 27.11.2020 13:13 Uhr
0
http://www.globenewswire.com/news-release/2020/11/27/2135245/0/en/Astellas-Receives-Approval-of-EVRENZO-roxadustat-in-Japan-for-the-Treatment-of-Anemia-of-Chronic-Kidney-Disease-in-Adult-Patients-Not-on-Dialysis.html
Summer.76
Summer.76, 05.11.2020 22:27 Uhr
0
FibroGen Reports Third Quarter 2020 Financial Results https://www.globenewswire.com/news-release/2020/11/05/2121451/0/en/FibroGen-Reports-Third-Quarter-2020-Financial-Results.html - Strong Third Quarter China Roxadustat Net Sales of $22.7 Million - ...
Summer.76
Summer.76, 03.11.2020 15:18 Uhr
0
https://pub.webull.com/us/news-html/2ed53ac64a2d4c70a7abbc5cb8a22fbf.html?theme=2&_v=1&color=1&hl=en&sp=1&_v=1&theme=2&color=1&hl=en&theme=1 FibroGen Inc (NASDAQ:FGEN) is a total spec and earnings won't matter, said Cramer. He likes the idea as long as investors put the stock in the total speculative column.
Summer.76
Summer.76, 22.10.2020 17:48 Uhr
0
https://www.globenewswire.com/news-release/2020/10/22/2112965/0/en/FibroGen-Presents-Late-Breaker-Abstract-Results-on-Associations-between-Hemoglobin-Levels-and-Cardiovascular-Outcomes-in-Roxadustat-Treated-Patients-with-Anemia-of-Chronic-Kidney-D.html
Summer.76
Summer.76, 03.09.2020 15:02 Uhr
0
https://endpts.com/akebia-shares-crater-as-their-phiii-anemia-drug-fails-on-safety-offering-rival-fibrogen-a-huge-advantage/ Akebia shares MACEd as their PhIII anemia drug fails on safety, offering rival FibroGen a huge advantage
Summer.76
Summer.76, 11.08.2020 17:25 Uhr
0
https://www.globenewswire.com/news-release/2020/08/11/2076245/0/en/FibroGen-Announces-First-Patient-Enrolled-in-Pamrevlumab-Phase-3-Clinical-Trial-in-Patients-with-Duchenne-Muscular-Dystrophy.html
Adler.
Adler., 07.08.2020 16:23 Uhr
0
Huiii ✌️
Summer.76
Summer.76, 07.08.2020 15:47 Uhr
0
*** = investing_
Summer.76
Summer.76, 07.08.2020 15:46 Uhr
0
Mizuho Securities Stick to Their Buy Rating for FibroGen https://www.***/news/mizuho-securities-stick-to-their-buy-rating-for-fibrogen-2258082 ...setting a price target of 72, which is approximately 68.82% above the present share price of 42.65. ...
Summer.76
Summer.76, 06.08.2020 22:48 Uhr
0
Bzw kurz: https://seekingalpha.com/news/3602426-fibrogen-eps-misses-0_39-misses-on-revenue FibroGen EPS misses by $0.39, misses on revenue FibroGen (NASDAQ:FGEN): Q2 GAAP EPS of -$0.95 misses by $0.39. Revenue of $42.89M (-77.6% Y/Y) misses by $5.4M.
Summer.76
Summer.76, 06.08.2020 22:43 Uhr
0
https://www.globenewswire.com/news-release/2020/08/06/2074568/0/en/FibroGen-Reports-Second-Quarter-2020-Financial-Results.html FibroGen Reports Second Quarter 2020 Financial Results
Summer.76
Summer.76, 23.06.2020 15:11 Uhr
0
https://www.globenewswire.com/news-release/2020/06/23/2051872/0/en/FibroGen-Announces-First-Patient-Enrolled-in-Pamrevlumab-Clinical-Trial-in-Patients-Hospitalized-in-U-S-with-Acute-COVID-19.html FibroGen gibt den ersten Patienten bekannt, der an einer klinischen Pamrevlumab-Studie bei Patienten mit akutem COVID-19 in den USA teilnimmt
Adler.
Adler., 22.06.2020 23:24 Uhr
0
👍👍👍
Summer.76
Summer.76, 22.06.2020 16:28 Uhr
0
http://www.globenewswire.com/news-release/2020/06/22/2051107/0/en/FibroGen-Appoints-Thane-Wettig-as-Chief-Commercial-Officer.html
Summer.76
Summer.76, 08.06.2020 15:22 Uhr
0
https://www.globenewswire.com/news-release/2020/06/08/2044807/0/en/FibroGen-Announces-First-Patient-Enrolled-in-Pamrevlumab-Clinical-Trial-in-Patients-Hospitalized-in-Italy-with-Severe-COVID-19.html
Adler.
Adler., 08.06.2020 14:18 Uhr
0
Yees ✌️
Meistdiskutiert
Thema
1 DeFi Technologies: Eine Perle? -4,64 %
2 Dynamite Blockchain -5,88 %
3 Metaplanet +0,35 %
4 NEL ASA Hauptdiskussion +1,55 %
5 PLUG POWER Hauptdiskussion +4,56 %
6 NVIDIA Hauptdiskussion +2,19 %
7 Der Gold Club von Susiwong +0,14 %
8 VONOVIA Hauptdiskussion +0,34 %
9 HauptForum SK HYNIC +3,22 %
10 DAX Prognose / Germany 40 +0,61 %
Alle Diskussionen
Aktien
Thema
1 DeFi Technologies: Eine Perle? -4,64 %
2 Metaplanet +0,35 %
3 Dynamite Blockchain -5,88 %
4 NEL ASA Hauptdiskussion +1,55 %
5 NVIDIA Hauptdiskussion +2,18 %
6 PLUG POWER Hauptdiskussion +4,61 %
7 HauptForum SK HYNIC +3,22 %
8 VONOVIA Hauptdiskussion +0,34 %
9 NIKE Hauptdiskussion -2,97 %
10 SERVICENOW Hauptdiskussion -2,41 %
Alle Diskussionen